🇺🇸 FDA
Pipeline program

pyroglutamate rongliflozin capsules

DJT1116PG-DM-105

Phase 1 small_molecule completed

Quick answer

pyroglutamate rongliflozin capsules for Diabetes Mellitus, Type 2 is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Diabetes Mellitus, Type 2
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials